13 completed, 4 terminated, 2 unknown, 1 active not recruiting. 7 Phase 3, 4 Phase 2, 3 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Terminated 4, Completed 3 |
| Phase 2 | 4 | Completed 4 |
| Not applicable | 3 | Completed 2, Withdrawn 1 |
| Phase 4 | 1 | Completed 1 |
Follow Proctitis: new trials by email Literature Review of Proctitis trials Research Report on Proctitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Prevalence of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Patients Suspected of Hemorrhagic Proctosigmoiditis Anal swap for Chlamydia and Gonorrhoea - Proctitis, Ulcerative, Sexually Transmitted Disease (STD) | Active not recruiting | University of Aarhus | 214 | 2024-10-01 | 2025-11-18 | |
| Role of FCI in the Detection of Proctosigmoiditis Caused by IBD Field-cycling imaging (FCI) - Inflammatory Bowel Diseases, Proctosigmoiditis | Not applicable | Withdrawn | NHS Grampian | 2024-03-01 | 2024-05-14 | |
| New Local Treatment of Radiation-induced Proctitis Ziverel - Radiation Proctitis | Unknown | Barmherzige Brüder Vienna | 50 | 2022-07-01 | 2022-08-05 | |
| Pilot Study for the Evaluation of Food Choices in Patients With Inflammatory Bowel Diseases (MICI2021) Inflammatory Bowel Diseases | Unknown | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 45 | 2021-04-01 | 2021-10-15 | |
| Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis GT3X Actigraph accelerometer. - Crohn's Enteritis, Crohn Disease | Completed | University Hospital, Lille | 100 | 2020-09-01 | 2026-04-21 | |
| Phenomics in Autoimmune and Inflammatory Diseases 1: AID groups, 2: Control groups - Healthy Volunteer, Rheumatoid Arthritis | Completed | Assistance Publique - Hôpitaux de Paris | 537 | 2015-07-29 | 2023-08-08 | |
| Faecal Incontinence iNtervention Study IBD nurse intervention - Fecal Incontinence, Inflammatory Bowel Disease (IBD) | Not applicable | Completed | London North West Healthcare NHS Trust | 67 | 2015-05-01 | 2018-08-28 |
| Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution oral food challenge 1, oral food challenge 2 - Food Allergy in Infants, Proctocolitis | Completed | Hôpital Armand Trousseau | 100 | 2014-05-01 | 2020-12-03 | |
| Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis Budesonide 2 mg suppository, Budesonide 4 mg suppository, Mesalazine 1 g suppository - Proctitis | Phase 2 | Completed | Dr. Falk Pharma GmbH | 320 | 2013-09-01 | 2019-05-07 |
| Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis Photopill treatment - Ulcerative Colitis, Proctitis | Phase 2 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 8 | 2013-01-01 | 2015-06-23 |
| Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis Rectal tacrolimus, Placebo - Ulcerative Colitis | Phase 4 | Completed | The University of Western Australia | 21 | 2012-10-01 | 2016-12-15 |
| Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms Symbiotic, Maltodextrin - Radiation Proctitis, Prostate Cancer | Phase 2 / Phase 3 | Completed | Federal University of Mato Grosso | 20 | 2012-01-01 | 2013-07-17 |
| The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis Budesonide Foam - Proctitis, Proctosigmoiditis | Phase 3 | Terminated | Bausch Health Americas, Inc. | 114 | 2011-05-31 | 2019-08-14 |
| Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities Inflammatory Bowel Diseases | Completed | Centre Hospitalier Universitaire de Saint Etienne | 194 | 2010-10-01 | 2011-11-03 | |
| Clinical Trial With Mesalamine 1g Suppositories Mesalamine, Canasa, Placebo - Proctitis | Phase 3 | Terminated | Sandoz | 158 | 2010-06-01 | 2017-03-27 |
| Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis PUR 0110 Rectal Enema 250 mg, PUR 0110 Rectal Enema 500 mg, PUR 0110 Rectal Enema 1000 mg - Left-Sided Ulcerative Colitis, Proctosigmoiditis | Phase 2 | Completed | PurGenesis Technologies Inc. | 34 | 2010-06-01 | 2018-05-01 |
| RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS. Aloe vera gel - Aloe Vera Gel, Proctosigmoiditis, Remission, Trial, Ulcerative Colitis (UC) | Not applicable | Completed | Ospedale Sandro Pertini, Roma | 44 | 2010-03-10 | 2021-02-15 |
| Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis MAX-002, Placebo, Canasa® - Proctitis, Ulcerative | Phase 3 | Terminated | Forest Laboratories | 119 | 2009-11-30 | 2019-08-28 |
| Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis Budesonide, Placebo - Proctitis, Proctosigmoiditis | Phase 3 | Completed | Bausch Health Americas, Inc. | 281 | 2009-11-20 | 2019-08-14 |
| Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis Budesonide, Placebo - Proctitis, Proctosigmoiditis | Phase 3 | Completed | Bausch Health Americas, Inc. | 265 | 2009-11-17 | 2019-08-14 |
Showing 20 of 21. Sign in to see all of them.
Proctocolitis (12) · Inflammatory Bowel Diseases (10) · Colitis, Ulcerative (7) · Ulcer (5) · Colonic Diseases (4) · Crohn Disease (4) · Gastrointestinal Diseases (4) · Colitis (3) · Digestive System Diseases (3) · Gastroenteritis (3) · Intestinal Diseases (3) · Pathologic Processes (3) · Rectal Diseases (3) · Sigmoid Diseases (3)
Digestive System Diseases (18) · Gastroenteritis (18) · Intestinal Diseases (18) · Rectal Diseases (18) · Gastrointestinal Diseases (17) · Colitis (11) · Colonic Diseases (10) · Sigmoid Diseases (9) · Pathological Conditions, Signs and Symptoms (5) · Immune System Diseases (3) · Inflammatory Bowel Diseases (3) · Urogenital Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2)
Budesonide (3) · Mesalamine (3) · Aloe vera gel (1) · Calcineurin Inhibitors (1) · Hyperbaric Oxygenation (1) · Suppositories (1) · maltodextrin (1)
Bausch Health Americas, Inc. (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Assistance Publique - Hôpitaux de Paris (1) · Barmherzige Brüder Vienna (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Dr. Falk Pharma GmbH (1) · Federal University of Mato Grosso (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Forest Laboratories (1) · Hôpital Armand Trousseau (1) · London North West Healthcare NHS Trust (1) · NHS Grampian (1) · National Baromedical Services (1) · Ospedale Sandro Pertini, Roma (1) · PurGenesis Technologies Inc. (1)
United States (5) · France (4) · Australia (2) · Germany (2) · United Kingdom (2) · Austria (1) · Canada (1) · Denmark (1) · India (1) · Italy (1) · Mexico (1) · Netherlands (1) · Poland (1) · South Africa (1) · Turkey (Türkiye) (1)
Anders K Dige, Consultant, Ph.D. (1) · Bernhard Dauser, Assoc. Prof. (1) · Britta Siegmund, Professor (1) · Christan L Hvass, Professor (1) · Christine Norton, PhD (1) · Dick Clarke, CHT (1) · Geert R D'Haens, MD (1) · Gillian Bain, Dr (1) · Ian C Lawrance, MBBS PhD (1) · Line Kibsgaard, MD, Ph.D. (1)
PMID 25644096, PMID 27416045, PMID 22271464, PMID 26445224, PMID 27245762, PMID 28286194, PMID 29702300, PMID 30166293, PMID 32172690, PMID 32558265, PMID 3317057, PMID 36220315, PMID 38182406, PMID 41862407, PMID 6102236
2009 (1)